Risk Factors ID’d for Severe COVID-19 With Sickle Cell Disease
Hydroxyurea use does not impact development of serious COVID-19 or need for hospitalization in children or adults
Review Compiles Myocarditis Cases Associated With COVID-19
COVID-19-related myocarditis profiled from 42 cases reported in articles published from December 2019 through January 5, 2021
Iron Deficiency May Increase Mortality, CV Risks in Nondialysis CKD
Iron deficiency, indicated by low transferrin saturation, tied to higher mortality, CV event risks in nondialysis CKD patients with or without anemia
Athletes Have Higher Risk for Developing Atrial Fibrillation
Risk greater in athletes younger than 55 years and among those participating in mixed sport versus endurance sport
Burnout Symptoms Present in More Than One in Four Cardiologists
Leading cardiology associations identify drivers associated with burnout, including lack of control over workload, hectic work environment
Teen, Parent Response Explored for Cardiomyopathy Genetic Tests
Families with positive predictive test results had better functioning scores than those with negative predictive test results
Omega-3 Fatty Acids Tied to Better Cardiovascular Outcomes
Cardiovascular risk reduction more prominent with EPA monotherapy versus EPA + DHA therapy
Cardiovascular Drugs Do Not Impact COVID-19 Outcomes
Authors say patients even with COVID-19 should continue taking cardiovascular drugs as prescribed
Risk for Atherosclerotic CVD Increased With South Asian Ancestry
Higher risk persisted after adjustment for broad range of clinical, anthropometric, and lifestyle risk factors
ACIP: Benefits of mRNA COVID-19 Vaccines Outweigh Risks for ≥12s
After reviewing evidence, including data on risks for myocarditis, vaccination benefits outweigh risks for all populations
